Product Images 0.5% Lidocaine Hcl

This is a 50mL vial of 0.5% Lidocaine HCl injection, USP with a concentration of 250mg/58nL (or Smg/mL). It is marked as for prescription use only.*

This is a description of a medication called Lidocaine HCL Injection in a 250mg/50mL (5%) single-use vial. It comes in a case of 25 vials and is for prescription use only.*

This text appears to be a list of different concentrations and sizes of pharmaceutical packaging. The items listed include: 1% concentration in 30mL single-dose tear-top vials, 1.5% concentration in 20mL single-dose ampuls, 2% concentration in 10mL single-dose ampuls. It is possible that these are medications or drugs, but without further context or information, it is impossible to say for certain.*

This is a table outlining recommended dosages for Lidocaine Hydrochloride Injection, with information about concentrations and recommended amounts for various types of anesthesia, including infiltration, intravenous regional, peripheral nerve blocks, and sympathetic nerve blocks. The table also includes information about the recommended dose for anesthesia and analgesia for specific procedures, such as dental and obstetrical analgesia. The recommended dose is determined by the number of dermatomes to be anesthetized.*

This text represents the concentration and the quantity of lidocaine HCL and sodium chloride in different proportions. Lidocaine HCl is present at concentrations of 0.5%, 1%, 1.5%, 2%, and the corresponding amounts in mg/mL in each concentration are 5, 10, 15, and 20. Likewise, the sodium chloride amounts in mg/mL are 8, 7, 6.5, and 6, respectively, for the corresponding lidocaine HCl concentrations. This information can be useful for pharmacists, doctors, and researchers who work with lidocaine HCl and its different dilutions.*

This is a list of drugs that can cause methemoglobinemia, a condition in which the oxygen-carrying capacity of the blood is decreased. The drugs are divided into several classes, including nitrates/nitrites, local anesthetics, antineoplastics, antibiotics, antimalarials, and anticonvulsants. Examples of specific drugs in each class are provided. Additionally, some other drugs like acetaminophen, metoclopramide, quinine, and sulfasalazine can also cause methemoglobinemia.*

This is a description of a pharmaceutical product called Lidocaine HCI 0.05% Injection, USP, which comes in a 50 mL single-dose preservative-free container with NDC 0409-4278-16. The product is distributed by Hospira, Inc, located in Lake Forest, IL, USA. It is intended for infiltration technique, including percutaneous injection and intravenous regional anesthesia. Each mL of the product contains lidocaine hydrochloride, and 5 mg which may contain HCl and/or NaOH for pH adjustment. It is sterile, nonpyrogenic, and has a pH range of 5.0 to 7.0. The recommended dosage can be found in the insert, and after use, any unused portion should be discarded. The product should be stored at controlled room temperature, between 20 to 25°C (68 to 77°F) as per the USP guideline. The product has lot number and expiration date, LOT ##-#HH-AA, EXP DMMMYYYY, respectively.*